Study of oxidative damage and antioxidant systems in two Huntington's disease rodent models

Methods in Molecular Biology

Volumn 1010, Issue , 2013, Pages 177-200

  Pérez Severiano, Francisca ^a   Montes, Sergio ^a   Gerónimo Olvera, Cristian ^a   Segovia, José ^b  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Dihydroethidium; Free radicals; Genotyping; Lipid peroxidation; Neurological phenotype; Nitric oxide synthase; Oxidized glutathione; Quinolinic acid; Reactive oxygen species; Striatal oxidative damage; Superoxide dismutase; Transgenic mice

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; KYNURENINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; QUINOLINIC ACID; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; EXCITOTOXICITY; FEMALE; HUNTINGTON CHOREA; LIPID PEROXIDATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 84880392168     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-411-1_12     Document Type: Article

References (32)

1. Browne SE, Bowling AC, MacGarvey U et al (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia. Ann Neurol 41:646-653
2. Segovia J, Arregui L (2007) Mechanisms of neuronal death associated to Huntington's disease. In: Massieu L, Arias C, Moran J (eds) The neurochemistry of neuronal death. Research Signpost, Trivandrum, p 197
3. Polidori MC, Mecocci P, Browne SE et al (1999) Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex. Neurosci Lett 272:53-56
4. Arregui L, Segovia J (2004) Molecular strategies for the treatment of Huntington's disease. Curr Pharmacogenomics 2:299-311
5. Arregui L, Segovia J (2009) Transgenic murine models for Huntington's disease. In: Rocha Arrieta LL, Granados-Soto V (eds) Models of neuropharmacology. Transworld Research Network, Trivandrum, p 35
6. Ross CA, Tabrizi SJ (2011) Huntington's disease: From molecular pathogenesis to clinical treatment. Lancet Neurol 10:83-98
7. Beal MF, Kowall NW, Ellison DW et al (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321:168-171
8. Stone TW (1999) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45:309-379
9. Perez-Severiano F, Escalante B, Rios C (1998) Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity. Neurochem Res 23:1297-1302
10. Schwarcz R, Guidetti P, Sathyasaikumar KV et al (2010) Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease. Prog Neurobiol 90:230-245
11. Sies H (1999) Glutathione and its role in cellular function. Free Radic Biol Med 27:916-921
12. Mangiarini L, Sathasivam K, Seller M et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is suf fi cient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506
13. Segovia J (2002) Transgenic model for the study of oxidative damage in Huntington's disease. Methods Enzymol 353:365-373
14. Pérez-Severiano F, Ríos C, Segovia J (2000) Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease. Brain Res 862:234-237
15. Paxinos G, Watson G (1984) The rat brain in stereotaxic coordinates. Academic, Sydney
16. Gutteridge JM, Halliwell B (1990) The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15:129-135
17. Chan PH, Yurko M, Fishman RA (1982) Phospholipid degradation and cellular edema induced by free radicals in brain cortical slices. J Neurochem 38:525-531
18. Lowry OH, Rosebrougth NJ, Farr AL et al (1951) Protein measurement with the folinphenol reagent. J Biol Chem 193:265-275
19. Perez-Severiano F, Santamaria A, Pedraza-Chaverri J et al (2004) Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington's disease mutation. Neurochem Res 29:729-733
20. Bindokas VP, Jordán J, Lee CC et al (1996) Superoxide production in rat hippocampal neurons: Selective imaging with hydroethidine. J Neurosci 16:1324-1336
21. Zhao H, Joseph J, Fales HM et al (2005) Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fl uorescence. Proc Natl Acad Sci USA 102:5727-5732
22. Arellano-Mendoza MG, Castillo-Henkel C, Medina-Santillan R et al (2008) Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase (-/-) mice and improved by combined administration of L-Arginine and antioxidants. Nephrology (Carlton) 13:218-227
23. Schuman EM, Madison DV (1994) Nitric oxide and synaptic function. Annu Rev Neurosci 17:153-183
24. Bredt DS, Snyder SH (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87:682-685
25. Pérez-Severiano F, Escalante B, Vergara P et al (2002) Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's Disease mutation. Brain Res 862:234-237
26. Díaz-Barriga F, Hernández JM, Carrizales L et al (1989) Interactions of cadmium with actin micro fi laments. Toxicol In Vitro 3:277-284
27. Oberley LW, Spitz DR (1984) Assay of superoxide dismutase activity in tumor tissue. Methods Enzymol 105:457-464
28. Iqbal J, Whitney P (1991) Use of cyanide and diethyldithiocarbamate in the assay of superoxide dismutases. Free Radic Biol Med 10:69-77
29. Santamaría A, Pérez-Severiano F, Rodríguez- Martínez E et al (2001) Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington's disease. Neurochem Res 26:419-424
30. Bharath S, Hsu M, Kaur D et al (2002) Glutathione and Parkinson's disease. Biochem Pharmacol 64:1037-1048
31. Hissing PJ, Hilf R (1976) A fl ourometric method for the determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214-226
32. Triggs WP, Willmore LJ (1984) In vivo lipid peroxidation in rat brain following intracortical Fe++ injection. J Neurochem 42:976-979